IP Library › Granted Patent US 6,849,261
Granted Patent B2
US 6,849,261 · App. 10/196,515 · Granted Feb 1, 2005

CD4-independent HIV envelope proteins as vaccines and therapeutics

Assignee: The Trustees of the University of Pennsylvania
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,849,261
App. No.
10/196,515
Granted
Feb 1, 2005
Kind
B2
Abstract

The invention relates to novel CD4-independent HIV Envelope proteins and uses therefor.

Claims (6)

1. An isolated polypeptide comprising an HIV-1/IIIBx 8x Env, said isolated polypeptide comprising the amino acid sequence of SEQ ID NO:3.

2. A cell comprising the isolated polypeptide of claim 1 .

3. The cell of claim 2 , wherein said cell is a prokaryotic cell.

4. The cell of claim 2 , wherein said cell is a eukaryotic cell.

5. The cell of claim 4 , wherein said eukaryotic cell is selected from the group consisting of a fungal cell, an insect cell, and a mammalian cell.

6. A composition comprising the isolated polypeptide of claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 27, 2022
From: UNIVERSITY OF PENNSYLVANIA
To: NIH - DEITR
Reel/Frame 061883/0974 →
Continuity (3)
Division 0933738700 · Jun 22, 1999
Continuation In Part 0931755600 · May 24, 1999
Related Publication 20030091594A1 · May 15, 2003